Literature DB >> 18175400

Management of motor complications in advanced Parkinson's disease.

Eldad Melamed1, Ilan Ziv, Ruth Djaldetti.   

Abstract

After several years of smooth and stable response to levodopa, many patients develop motor fluctuations manifested by "on" and "off" phases. There are various subtypes of motor fluctuations that have different underlying mechanisms and therapeutical strategies. The "wearing off" phenomenon may be mainly due to the loss of stratial dopamine storage capacity and short levodopa half-life. The "delayed on" and "no-on" phenomena may be due to impaired absorption of oral levodopa. Management include various combined approaches, such as administration of small multiple daily doses of levodopa, controlled release, dispersible and soluble levodopa formulations, oral dermal- patch and subcutaneous dopamine agonists, MAO-B and COMT inhibitors, and surgical approaches, i.e., subthalamic deep brain stimulation. Future strategies may include gene therapy (e.g., intrastriatal GDNF) or transplantation of stem cells that can either produce and release dopamine or generate trophical factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18175400     DOI: 10.1002/mds.21680

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  11 in total

Review 1.  Surgical Treatment of Parkinson's Disease.

Authors:  Leo Verhagen Metman; Gian Pal; Konstantin Slavin
Journal:  Curr Treat Options Neurol       Date:  2016-11       Impact factor: 3.598

2.  The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.

Authors:  Saurabh Sen; Andrew B West
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

3.  Part 2: Introduction to the Pharmacotherapy of Parkinson's Disease, With a Focus on the Use of Dopaminergic Agents.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-09

4.  Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats.

Authors:  Christopher Bishop; David M Krolewski; Karen L Eskow; Christopher J Barnum; Kristin B Dupre; Terrence Deak; Paul D Walker
Journal:  J Neurosci Res       Date:  2009-05-15       Impact factor: 4.164

5.  Parkinson's Disease and Its Management: Part 4: Treatment of Motor Complications.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-11

6.  Impact of Residual Drug in the Pharynx on the Delayed-On Phenomenon in Parkinson's Disease Patients.

Authors:  Jiro Fukae; Shinsuke Fujioka; George Umemoto; Hajime Arahata; Shosaburo Yanamoto; Takayasu Mishima; Yoshio Tsuboi
Journal:  Mov Disord Clin Pract       Date:  2020-02-27

7.  Open Label Trial of the Efficacy and Safety Profile of Rikkunshito used for the Treatment of Gastrointestinal Symptoms in Patients with Parkinson's Disease: A Pilot Study.

Authors:  Koji Yakabi; Naomi Yamaguchi; Shino Ono; Norihito Yoshida; Eriko Hosomi; Kenjiro Hayashi; Mitsuko Ochiai; Kosuke Maezawa; Kyoichi Nomura
Journal:  Curr Ther Res Clin Exp       Date:  2017-07-31

8.  Clinical aspects of palliative care in advanced Parkinson's disease.

Authors:  Johan Lokk; Ahmad Delbari
Journal:  BMC Palliat Care       Date:  2012-10-25       Impact factor: 3.234

Review 9.  Acupuncture and Related Therapies for Symptom Management in Palliative Cancer Care: Systematic Review and Meta-Analysis.

Authors:  Charlotte H Y Lau; Xinyin Wu; Vincent C H Chung; Xin Liu; Edwin P Hui; Holger Cramer; Romy Lauche; Samuel Y S Wong; Alexander Y L Lau; Regina W S Sit; Eric T C Ziea; Bacon F L Ng; Justin C Y Wu
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 10.  Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and Rehabilitation.

Authors:  Francesca Magrinelli; Alessandro Picelli; Pierluigi Tocco; Angela Federico; Laura Roncari; Nicola Smania; Giampietro Zanette; Stefano Tamburin
Journal:  Parkinsons Dis       Date:  2016-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.